Randomised clinical trial: the 5‐HT4 agonist revexepride in patients with gastro‐oesophageal reflux disease who have persistent symptoms despite PPI therapy

por Shaheen, N. J., Adler, J., Dedrie, S., Johnson, D., Malfertheiner, P., Miner, P., Meulemans, A., Poole, L., Tack, J., Thielemans, L., Troy, S., Vakil, N., Zerbib, F., Ruth, M.
Publicado 2015

Randomized clinical trial: effect of the 5-HT(4) receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment

por Tack, J, Zerbib, F, Blondeau, K, des Varannes, S B, Piessevaux, H, Borovicka, J, Mion, F, Fox, M, Bredenoord, A J, Louis, H, Dedrie, S, Hoppenbrouwers, M, Meulemans, A, Rykx, A, Thielemans, L, Ruth, M
Publicado 2015

The European Project SIDARTHA using emergency care data for public health surveillance and health threat preparedness

por Lippert, F, Brattebø, G, Kettunen, T, Myrmel, L, Kurola, J, Ziemann, A, Krafft, T, Riesgo, L Garcia-Castrillo, Fischer, M, Kraemer, A, Vergeiner, G, Baer, M, Ozguler, A, Meulemans, A, Gillet, JB, Brand, H, Pinheiro, P, Rosenberg, M, Overton, J
Publicado 2009